Preparation and characterization of vaginal suppository of semisynthetic derivatives of ergot alkaloids cabergoline
Open Access
- 1 December 2023
- journal article
- research article
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 31 (12) , 101849
Abstract
Background: There is evidence that vaginal cabergoline can help to prevent ovarian hyperstimulation syndrome. Therefore, the vaginal suppository may be a good choice because it can be administered directly into the vagina and has no adverse effects on the stomach. In this regard we developed a cabergoline suppository as an alternative to cabergoline tablets. Design-Expert was used to determine the most suitable concentrations of PEG 6000/400, and Tween 80 to obtain a stable suppository. Specific ratios of PEG6000/400 and Tween 80 were entered as factors, and release, melting time, and hardness were evaluated as responses. In addition, the final formulation was evaluated for weight changes, pH, drug content, degradation time, deformation time, in vitro drug release, DSC analysis, infrared spectroscopy, and stability properties. Results: The suppositories were all smooth and white. They all had a weight that averaged less than 5 %. The formulations showed a pH between 6 and 6.5. The active ingredient content ranged between 79.666 ± 8.54 % and 99.67 ± 6.55 %. Suppository stiffness was between 2.74 ± 0.04 and 4.20 ± 0.03. The decomposition time of the suppositories varied between 11.25 ± 0.15 to 20.19 ± 0.08 min. The deformation time was between 26.11 ± 0.06 to 38.59 ± 0.47 min. Cabergoline content was released over 45 min from formulations of F10 (∼46 %), F2 (∼64 %), F6 (∼69 %), F4 (∼79 %), F1 (∼88 %), and F7 (∼93 %). However, other formulations released more than 95 % within 45 min. Conclusions: All variables except melting time significantly affected our responses. In vitro studies have indicated that the optimized cabergoline formula could be an excellent alternative to cabergoline oral formulations.Keywords
Funding Information
- Mashhad University of Medical Sciences
This publication has 45 references indexed in Scilit:
- Pharmaceutical development and optimization of azithromycin suppository for paediatric useInternational Journal of Pharmaceutics, 2013
- BDDCS Applied to Over 900 DrugsThe AAPS Journal, 2011
- Diagnosis and Management of Bacterial Vaginosis and Other Types of Abnormal Vaginal Bacterial Flora: A ReviewObstetrical & Gynecological Survey, 2010
- Intranasal Cabergoline: Pharmacokinetic and Pharmacodynamic StudiesAAPS PharmSciTech, 2009
- Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2Journal of Cell Science, 2009
- Clinical Pharmacokinetics of CabergolineClinical Pharmacokinetics, 2003
- CabergolineExpert Opinion on Pharmacotherapy, 2000
- Effects of cabergoline in a pituitary adenoma secreting follicle-stimulating hormone1997
- In vivo Effect of Cabergoline, a Dopamine Agonist, on Estrogen-Induced Rat Pituitary Tumors.Endocrine Journal, 1995
- L. J. Bellamy: The Infrared Spectra of Complex Molecules, Vol. 1, 3. Auflage, Chapman and Hall Ltd., London 1975, 433 Seiten, 32 Abb., 22 Tabellen, Preis: £ 8.—.Berichte der Bunsengesellschaft für physikalische Chemie, 1976